Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity.
Huang Y, Liu W, Zhao C, Shi X, Zhao Q, Jia J, Wang A.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116547 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för istisociclib. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
7 träffarRecent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications.
Zhang Y, Shan L, Tang W, Ge Y, Li C, Zhang J.
J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jmedchem.4c00312Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers.
Freeman DB, Hopkins TD, Mikochik PJ, Vacca JP, Gao H, Naylor-Olsen A, Rudra S, Li H, Pop MS, Villagomez RA, Lee C, Li H, Zhou M, Saffran DC, Rioux N, Hood TR, Day MAL, McKeown MR, Lin CY, Bischofberger N, Trotter BW.
J Med Chem · research-article; journal article · DOI 10.1021/acs.jmedchem.3c01233Design, synthesis, and biological evaluation of novel 4,4'-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer.
Gao G, Li J, Cao Y, Li X, Qian Y, Wang X, Li M, Qiu Y, Wu T, Wang L, Fang M.
Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2023.115858From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
Shi Z, Tian L, Qiang T, Li J, Xing Y, Ren X, Liu C, Liang C.
J Med Chem · research support, non-u.s. gov't; systematic review; journal article · DOI 10.1021/acs.jmedchem.1c02064CDK9 inhibitors in cancer research.
Huang Z, Wang T, Wang C, Fan Y.
RSC Med Chem · review-article; review; journal article · DOI 10.1039/d2md00040gLessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts.
Xie Z, Hou S, Yang X, Duan Y, Han J, Wang Q, Liao C.
J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jmedchem.1c02190